Science Explorer Interactive view Map
Company · Asker · Norway

Boehringer Ingelheim (Norway)

boehringer-ingelheim.no/?ROR OpenAlex
Research works
26
▼ 14% vs 2013–17
Citations
3.1k
116.7 per fractional work
Top-10% rate
28.4%
record average 16.5%
Open access
57%
world 28%

Not ranked overall: Boehringer Ingelheim (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Boehringer Ingelheim (Norway)?

Ranked on the composite score, Odd Erik Johansen lead among researchers whose main affiliation is Boehringer Ingelheim (Norway).

  1. 1 Odd Erik Johansen Norway · #1,263,562 worldwide 37 citations · 26 works
All ranked researchers at Boehringer Ingelheim (Norway)

Which keywords describe research at Boehringer Ingelheim (Norway)?

By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Heart Failure, Clinical Guidelines, Type 2 Diabetes, Cardiovascular Outcomes, Glucose Control and Cardiovascular Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Glycemic Control9▲ 257×4 topics
  2. Insulin Therapy9▲ 316×3 topics
  3. Heart Failure9▲ 72×3 topics
  4. Clinical Guidelines7▲ 84×2 topics
  5. Type 2 Diabetes7▲ 142×3 topics
  6. Cardiovascular Outcomes6▲ 578×1 topic
  7. Glucose Control6▲ 578×1 topic
  8. Cardiovascular Disease6▲ 19×11 topics
  9. Diabetes3▲ 25×6 topics
  10. Diabetes Mellitus3▲ 51×3 topics
  11. Obesity3▲ 15×7 topics
  12. Oxidative Stress3▲ 5.5×8 topics
  13. Complications2▲ 18×2 topics
  14. Continuous Glucose Monitoring2▲ 193×1 topic
  15. Hypoglycemia2▲ 193×1 topic
  16. Pancreatic Islets2▲ 120×1 topic
  17. ß-Cell Dysfunction2▲ 120×1 topic
  18. AMP-Activated Protein Kinase2▲ 142×1 topic
  19. Cancer Risk2▲ 28×3 topics
  20. Epidemiology2▲ 1.75×9 topics
  21. Metformin2▲ 174×1 topic
  22. Treatment2▲ 4.9×7 topics
  23. Diagnosis2▲ 6.0×3 topics
  24. Guidelines2▲ 12×2 topics
  25. Cardiovascular Risk2▲ 16×3 topics
  26. Inflammation1▲ 2.2×12 topics
  27. Global Burden1▲ 8.8×4 topics
  28. Chamber Quantification1▲ 58×1 topic
  29. Echocardiography1▲ 16×1 topic
  30. Hypertension1▲ 12×6 topics
  31. Metabolic Syndrome1▲ 4.6×6 topics
  32. B-Type Natriuretic Peptide1▲ 85×1 topic
  33. Hospital Readmission1▲ 85×1 topic
  34. Insulin Resistance1▲ 8.4×4 topics

Which research topics does Boehringer Ingelheim (Norway) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Pancreatic function and diabetes, Diabetes Management and Research and Cardiovascular Function and Risk Factors.

Diabetes Treatment and M…0Diabetes Treatment and Management: 0 fractional worksPancreatic function and …0Pancreatic function and diabetes: 0 fractional worksDiabetes Management and …0Diabetes Management and Research: 0 fractional worksCardiovascular Function …0Cardiovascular Function and Risk Factors: 0 fractional worksNursing Diagnosis and Documentation: 0 fractional worksAtrial Fibrillation Management and Outcomes: 0 fractional worksMetabolism, Diabetes, and Cancer: 0 fractional worksHyperglycemia and glycemic control in critically ill and hospitalized patients: 0 fractional worksHeart Failure Treatment and Management: 0 fractional worksChronic Kidney Disease and Diabetes: 0 fractional works
Endocrinology, Diabetes and MetabolismSurgeryCardiology and Cardiovascular MedicineIssues, ethics and legal aspects2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  2. 2 Pancreatic function and diabetes Surgery 0 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  4. 4 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  5. 5 Nursing Diagnosis and Documentation Issues, ethics and legal aspects 0 works
  6. 6 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  7. 7 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  8. 8 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
  10. 10 Chronic Kidney Disease and Diabetes Nephrology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.6%not open43.4%

World: 28% of research is openly available.

with international co-authors78.4%domestic only21.6%

World: 19% is written across borders.

How has Boehringer Ingelheim (Norway)'s research output changed?

Output in 2018–2022 was 14% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Asker

All research institutions in Asker

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.